Central nervous system T-cell lymphoproliferative disorder in a patient with chronic active Epstein-Barr virus infection

Journal of Pediatric Hematology/Oncology

Volumn 21, Issue 1, 1999, Pages 42-46

  Ohga, Shouichi ^a   Takada, Hidetoshi ^a   Honda, Keiko ^a   Inamura, Takanori ^a   Gondo, Kenjiro ^a   Ohshima, Kohichi ^b   Yamamoto, Masahiro ^a   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

Central nervous system; Chronic active Epstein Barr virus infection; Lymphoproliferative disorder

Indexed keywords

ALPHA INTERFERON; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CYTARABINE; HYDROCORTISONE;

ARTICLE; BRAIN BIOPSY; CASE REPORT; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; EPSTEIN BARR VIRUS; FEVER; HEPATOSPLENOMEGALY; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LABORATORY TEST; LYMPHOPROLIFERATIVE DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REMISSION; SERODIAGNOSIS; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

EID: 0033036382     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199901000-00009     Document Type: Article

References (29)

1. Elenitoba-Johnson KSJ, Jaffe ES. Lymphoproliferative disorders associated with congenital immunodeficiences. Semin Diagn Pathol 1997;14:35-47.
2. Shapiro RS, McClain K, Frizzera G, et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 1988;71:1234-43.
3. Pallesen G, Hamilton-Dutoit SJ, Zou X. The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: two new developments in the EBV field. Adv Cancer Res 1993;62:179-239.
4. Lucas KG, Pollock KE, Emanuel DL. Post-transplant Epstein-Barr virus induced lymphoproliferative disorders. Leuk Lymphoma 1997;25:1-8.
5. DeAngelis LM. Primary brain tumours in the acquired immunodeficiency syndrome. Curr Opin Neurol 1995;8:419-23.
6. Morrison VA, Dunn DL, Manivel JC, et al. Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 1994;97:14-24.
7. Straus SE. The chronic mononucleosis syndrome. J Infect Dis 1988;157:405-12.
8. Okano M, Matsumoto S, Osato T, et al. Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev 1991;4:129-35.
9. Ishihara S, Okada S, Wakiguchi H, et al. Chronic active Epstein-Barr virus infection in children in Japan. Acta Paediatr 1995;84:1271-5.
10. Ohga S, Matsuzaki A, Tokunaga K, et al. Clonal dissemination of Epstein-Barr (EB) virus in a patient with fatal chronic active EBV infection. Int J Pediatr Hematol Oncol 1994;1:305-10.
11. Ohshima K, Kikuchi M, Mizuno S, et al. Hepatosinusoidal leukemia/lymphoma consisting of Epstein-Barr virus-containing natural killer cell leukemia/lymphoma and T-cell lymphoma: mimicking malignant histiocytosis. Hematol Oncol 1995;13:83-97.
12. Grose C, Henle W, Henle G, et al. Primary Epstein-Barr virus infections in acute neurologic disorders. N Engl J Med 1975;292:392-5.
13. Tolly TL, Wells RG, Sty JR. MR features of fleeing CNS lesions associated with Epstein-Barr virus infection. J Comput Assist Tomogr 1989;13:665-8.
14. Shoji H, Kusuhara T, Honda Y, et al. Relapsing acute disseminated encephalomyelitis associated with Epstein-Barr virus infection: MRI findings. Neuroradiology 1992;34:340-2.
15. Dorr V, Doolittle G, Woodroof J. First report of a B cell lymphoproliferative disorder arising in a patient treated with immune suppressants for severe aplastic anemia. Am J Hematol 1996;52:108-13.
16. Mustafa MM, Winick NJ, Margraf LR. Epstein-Barr virus lymphoproliferative disorder in children with leukemia: case report and review of the literature. J Pediatr Hematol Oncol 1997;19:77-81.
17. Chao NJ, Berry GL, Advani R, et al. Epstein-Barr virus-associated lymphoproliferative disorder following autologous bone marrow transplantation for non-Hodgkin's lymphoma. Transplantation 1993;55:1425-8.
18. Emanuel DL, Lucas KG, Mallory GB Jr, et al. Treatment of post-transplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytes. Transplantation 1997;63:1691-4.
19. Yu GH, Montone KT, Frias-Hidvegi D, et al. Cytomorphology of primary CNS lymphoma: Review of 23 cases and evidence for the role of EBV. Diagn Cytopathol 1996;14:114-20.
20. Dean AE, Diss TC, Wotherspoon AC, et al. Histologic, molecular, and radiologic characterization of resolving cerebral posttransplant lymphoproliferative disorder. Pediatr Res 1997;41:651-6.
21. Rothenberg ME, Weber WEJ, Longtine JA, et al. Cytotoxic γ δ Τ lymphocytes associated with an Epstein-Barr virus-induced post-transplantation lymphoproliferative disorder. Clin Immunol Immunopathol 1996;80:266-72.
22. Paoli DP, Gennari D, Martelli P, et al. γ δ Τ cell receptor-bearing lymphocytes during Epstein-Barr virus infection. J Infect Dis 1990;11:1013-6.
23. Purtilo DT, Cassel CK, Yang JP, et al. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1975;7913:935-40.
24. Purtilo DT, Yang JP, Allegra S, et al. Hematopathology and pathogenesis of the X-linked recessive lymphoproliferative syndrome. Am J Med 1977;62:225-33.
25. Jones JF, Shurin S, Abramowsky C, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. Blood 1988;318-733-41.
26. Imai S, Sugiura M, Oikawa O, et al. Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood 1996;87:1446-57.
27. Kanegane H, Bhatia K, Gutierrez M, et al. A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma. Blood 1998;91: 2085-91.
28. Kikuta H, Sakiyama Y, Matsumoto S, et al. Detection of Epstein-Barr virus DNA in cardiac and aortic tissues from chronic, active Epstein-Barr virus infection associated with Kawasaki disease-like coronary artery aneurysm. J Pediatr 1993; 123:90-2.
29. Sakai Y, Ohga S, Tonegawa Y, et al. Interferon-α therapy for chronic active Epstein-Barr virus infection: potential effect on the development of T-lymphoproliferative disease. J Pediatr Hematol Oncol 1998;20:342-6.